abca1

IMM-H007 是一种新型降脂剂，可增加 abca1 蛋白的表达。

GSK3987 是广谱LXRα β激动剂，EC50分别为 50 nM 和 40 nM。GSK3987增加 ABCA1 和 SREBP-1c 蛋白的表达，诱导细胞甘油三酯的积累和胆固醇流出。

OSBPL7-IN-1 是口服有效的氧甾醇结合蛋白样 7 (OSBPL7)抑制剂。它促进质膜上ABCA1的增加，但不影响 mRNA 表达。

E1231 是 SIRT1 的激活剂。 E1231 通过增强 ABCA1 表达来防止实验性动脉粥样硬化并降低血浆胆固醇和甘油三酯。

Erythrodiol 是一种橄榄油的成分，能够选择性抑制ABCA1蛋白的降解来促进胆固醇外流，有用于动脉粥样硬化的研究潜力。

IMB-808 is an effective partial dual agonist of liver X receptor α and β (LXRα/β) that promotes the expression of genes related to reverse cholesterol transport (including ABCA1 and ABCG1).

Isosilybin A 是从水飞蓟中分离出来的一种黄酮木脂素，可抑制癌细胞增殖并诱导 G1 期停滞和凋亡，通过靶向 Akt-NF-κB-雄激素受体轴激活前列腺癌细胞的凋亡机制，具有抗前列腺癌活性。

st-Ht31是一种由A-kinase锚定蛋白（AKAPs）的两亲螺旋域衍生的、可穿透细胞的硬脂化肽，它能够结合蛋白激酶A (PKA)。在使用50 µM浓度时，能降低PKA在细胞膜上的锚定，但不影响其在使用BHK-21成纤维细胞进行的报告基因分析中的活性。st-Ht31 (1和3 µM)能减少小鼠精子的电容和超活化，同时阻止体外受精。当使用50 µM浓度时，它还能促进表达ATP结合盒转运蛋白1 (ABCA1)的BHK-21细胞和RAW 264.7巨噬细胞中的胆固醇排出。

AZ-2 is an inducer of ABCA1 and apoE. It enhances ABCA1 activity and decreases P2X7 receptor activity. AZ-2 activates endogenous LXR signaling but shows no direct LXRα or LXRβ agonist activity.

Falcarindiol 是一种口服活性聚乙炔氧脂，能激活 PPARγ 并增加 ABCA1 表达，具有诱导细胞凋亡和自噬的功能。此外，Falcarindiol 还展现出抗炎、抗菌、抗癌和抗糖尿病等特性。

AZ-1 is an inducer of ABCA1 and apoE. It enhances ABCA1 activity and decreases P2X7 receptor activity. AZ-1 activates endogenous LXR signaling but shows no direct LXRα or LXRβ agonist activity.

C2 L-threo Ceramide is a bioactive sphingolipid and cell-permeable analog of naturally occurring ceramides. It stimulates cholesterol efflux in CHO cells expressing the human ABCA1 receptor when used at a concentration of 10 μM, however, this efflux is 50% less than that stimulated by C2 ceramide . C2 L-threo Ceramide inhibits IL-4 production by 17% in EL4 T cells stimulated with phorbol 12-myristate 13-acetate when used at a concentration of 10 μM. It also induces cell cycle arrest in the G0/G1 phase and a 7-fold increase in sphingosine accumulation as well as inhibits growth of HL-60 leukemia cells.

C2 Dihydro Ceramide (d18:0 2:0) (C2 Dihydroceramide) 是短链的神经酰胺，是神经酰胺合成前体，可刺激 ABCA1 介导的胆固醇外流。

E17110 is an LXRβ agonist. E17110 exhibited a significant activation effect on LXRβ (EC50: 0.72 μmol/L). E17110 also increased the expression of ABCA1 and ABCG1 in RAW264.7 macrophages. E17110 significantly decreased cellular lipid accumulation and promoted cholesterol efflux in RAW264.7 macrophages.

Cajanin has potential hypolipidemic effects,possibly via up-regulating the ABCA1 protein expression,subsequently resulting in increased macrophage cholesterol efflux and RCT, it can significantly improve basal glucose uptake in HepG2 cells, its improving effect is concentration dependent, it exhibits effects stronger than that of rosiglitazone, which has been used as an antidiabetic drug.

Tanshindiol C protects macrophages from oxLDL induced foam cell formation via activation of Prdx1/ABCA1 signaling and that Prdx1 may be a novel target for therapeutic intervention of atherosclerosis.It possesses a unique anti-cancer activity whose mechani

Pseudoprotodioscin 是一种呋喃葡糖苷，抑制SREBP1 2和microRNA 33a b 水平，降低胆固醇和甘油三酯合成相关的基因表达。